Apoptotic myocardial degeneration in thrombotic thrombocytopenic purpura

T N James1, J B Alperin

  • 1World Health Organization Cardiovascular Center, the Department of Medicine, University of Texas Medical Branch, Galveston 77555-0129, USA.

Insights

Thrombotic thrombocytopenic purpura (TTP) causes myocardial degeneration primarily through apoptosis, not necrosis. This finding offers insights into cardiac issues and reperfusion injuries.

Area of Science:

  • Cardiovascular Pathology
  • Cellular Biology
  • Hematology

Background:

  • Thrombotic thrombocytopenic purpura (TTP) frequently involves cardiac complications, including the conduction system.
  • Despite coronary artery platelet occlusions, TTP shows minimal myocardial necrosis, posing a diagnostic challenge.

Purpose of the Study:

  • To investigate if apoptosis is the underlying mechanism of myocardial degeneration observed in TTP.
  • To elucidate the cellular processes contributing to cardiac involvement in TTP.

Main Methods:

  • Examination of six TTP patient hearts using routine and immunohistochemical staining.
  • Analysis of myocardial and cardiac conduction system tissues, including sinus node, AV node, and His bundle.

Main Results:

  • Widespread platelet thrombi occluding small coronary arteries, particularly in the cardiac conduction system.
  • Myocardial degeneration characterized by lack of inflammation and intact myocytes, with TUNEL-positivity indicating apoptosis.
  • Focal myocardial degeneration in TTP is predominantly apoptotic.

Conclusions:

  • The cardiac degeneration in TTP is primarily driven by apoptosis.
  • Serotonin release from platelet aggregation may influence early platelet aggregations, potentially impacting cardiac events.
  • Findings may inform understanding of myocardial reperfusion injuries in procedures like angioplasty and thrombolysis.

Related Concept Videos

Phagocytosis of Apoptotic Cells01:17

Phagocytosis of Apoptotic Cells

Cells undergoing apoptosis form apoptotic bodies that must be removed immediately to prevent inflammation, autoimmune diseases, and necrosis. Phagocytosis is carried out by professional phagocytes such as macrophages or  immature dendritic cells. Non-professional phagocytes such as  epithelial cells and fibroblasts also take part in this process; however, they are not as effective as professional phagocytes. 
Normal cells contain receptors that prevent them from being recognized by phagocytes.
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...